Siponimod selectively enriched regulatory T and B lymphocytes in active secondary progressive multiple sclerosis patients
Homo sapiens
18 Downloadable Samples
Affymetrix Human Gene 2.1 ST Array (hugene21st)
Submitter Supplied Information
Description
Siponimod selectively enriched regulatory T and B lymphocytes in active secondary progressive multiple sclerosis patients: 20 SPMS baseline including 3 repeats, 19 treated with 5 placebo and 14 siponimod treated.